A diagnostic pitfall in iron-refractory microcytic hypochromic anemia with acquired ring sideroblasts initially treated as iron deficiency anemia—a case report - Scorecard - MDSpire
Advertisement
A diagnostic pitfall in iron-refractory microcytic hypochromic anemia with acquired ring sideroblasts initially treated as iron deficiency anemia—a case report
Clinical Scorecard: Misdiagnosis of Iron-Refractory Microcytic Hypochromic Anemia with Acquired Ring Sideroblasts Initially Mistaken for Iron Deficiency Anemia: A Case Study
At a Glance
Category
Detail
Condition
Key Mechanisms
Impaired iron utilization despite preserved or increased iron stores; presence of ring sideroblasts linked to case findings.
Target Population
Care Setting
Key Highlights
Add highlight about the importance of thorough medication history.
Guideline-Based Recommendations
Diagnosis
Reassess diagnosis when iron supplementation fails and iron indices are inconsistent with iron deficiency anemia.
Consider SF3B1 testing in the diagnostic process.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Pyridoxine supplementation may be beneficial in selected cases of sideroblastic anemia, particularly when linked to ALAS2 activity.
Clinical Best Practices
Emphasize the need for longitudinal follow-up in treatment attribution.
